Free Trial

Oberweis Asset Management Inc. Makes New $6.12 Million Investment in Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group logo with Medical background

Oberweis Asset Management Inc. bought a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 466,600 shares of the company's stock, valued at approximately $6,122,000. Oberweis Asset Management Inc. owned 0.54% of Pediatrix Medical Group at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of Pediatrix Medical Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock worth $141,861,000 after buying an additional 113,976 shares during the last quarter. Pacer Advisors Inc. acquired a new position in Pediatrix Medical Group during the fourth quarter valued at approximately $35,492,000. Boston Partners grew its stake in Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock valued at $25,922,000 after purchasing an additional 393,600 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Pediatrix Medical Group by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock worth $25,562,000 after purchasing an additional 11,045 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in shares of Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after purchasing an additional 1,500,485 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

Shares of MD traded up $0.11 during trading hours on Monday, hitting $12.36. The company had a trading volume of 483,836 shares, compared to its average volume of 840,193. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of -10.30, a PEG ratio of 1.74 and a beta of 1.32. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The business has a fifty day moving average of $14.04 and a 200-day moving average of $13.99. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MD has been the topic of a number of recent analyst reports. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research note on Friday, February 21st. Finally, Truist Financial cut their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $16.75.

Check Out Our Latest Analysis on MD

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

See Also

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines